Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |